Prostate cancer continues to be a major threat to men's health, the second most common cancer in men, in many countries. Therefore it is increasingly important that those faced with difficult clinical questions make the right decisions. Since the first volume was published in 2000, many debates pers
Challenges in Prostate Cancer, Second Edition
- Publisher
- Wiley-Blackwell
- Year
- 2006
- Tongue
- English
- Leaves
- 291
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Prostate cancer continues to be a major threat to men's health, the second most common cancer in men, in many countries. Therefore it is increasingly important that those faced with difficult clinical questions make the right decisions. Since the first volume was published in 2000, many debates persist but new controversies have also emerged, reflected in the chapters of this new volume. New authors have been recruited to give their insight into newer areas of this controversial topic.
Challenges in prostate cancer provides a series of state-of-the-art review articles, each of which addresses and answers a contentious question. It includes chapters on medical and surgical management of all stages of prostate cancer, clinical investigation, epidemiology, clinical trials and basic scientific research and covers issues such as the genetic basis of cancer, clinical economics and influence.
The authors have used their expertise to distil the available evidence into practical advice to be used by busy urologists in their day-to-day practice. And as well as being an overview of current practice many chapters attempt to give insights into the future direction of prostate cancer research and clinical management.Content:
Chapter 1 An Update on Biotechnology in the Assessment of Prostate Cancer (pages 1β16): Tim Lane, Jon Strefford and Tim Oliver
Chapter 2 What Can we Learn from Breast Cancer? (pages 17β25): Ludger Barthelmes and Christopher A. Gateley
Chapter 3 New Serum Markers for Prostate Cancer (pages 26β39): Bernhard Brehmer, Antonios Makris and Gerhard Jakse
Chapter 4 The History of Tissue Recombination Technology: Current and Future Research (pages 40β52): Kenichiro Ishii and Simon Hayward
Chapter 5 Why we Cannot use the Results of Non?Randomised Trials to Inform us About Treatment for Early Prostate Cancer? (pages 53β61): Malcolm Mason and John Staffurth
Chapter 6 Equivocal PSA Results and Free Total PSA Ratio (pages 63β75): Bob Djavan, Michael Dobrovits and Michael Marberger
Chapter 7 Equivocal Prostate Needle Biopsies (pages 76β84): Murali Varma and David Griffiths
Chapter 8 Prostate Biopsy: How Many Cores and Where From? (pages 85β96): Richard Clements
Chapter 9 Counselling Patients with Early Prostate Cancer (pages 97β111): Gail Beese and Christopher Edmunds
Chapter 10 The Role of Pelvic Node Dissection in Prostate Cancer (pages 112β123): Owen Niall and Jamie Kearsley
Chapter 11 Laparoscopic Radical Prostatectomy (pages 125β136): Mark Wright
Chapter 12 Endocrine Therapy for Prostate Cancer: The Latest (pages 137β152): A. Goyal and W. Bowsher
Chapter 13 The Role of Conservative Policies in the Treatment of Prostate Cancer (pages 153β166): Stijn de Vries, Christopher Bangma and Fritz Schroder
Chapter 14 Complementary and Alternative Therapies for Prostate Cancer (pages 167β177): Gary Deng and Barrie Cassileth
Chapter 15 Radical Prostatectomy After Radical Radiotherapy (pages 179β192): Amir Kaisary
Chapter 16 Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer (pages 193β208): Paul Jones and Neil Fenn
Chapter 17 Open Radical Prostatectomy: How Can Intra?Operative, Peri?Operative and Post?Operative Complications be Prevented? (pages 209β225): Robert P. Myers, R. Houston Thompson, Stephen M. Schatz and Michael L. Blute
Chapter 18 Documenting Prostate Cancer: Epidemiology and Treatment (pages 226β245): Leslie Moffat
Chapter 19 Trends in Prostate Cancer Incidence and Mortality (pages 246β257): Steven Oliver, Rhidian Hurle and Owen Hughes
Chapter 20 Chemotherapy in Prostate Cancer (pages 258β272): Jason Lester and Emma Hudson
π SIMILAR VOLUMES
When a patient is told that his prostate cancer has progressed to a new stage, he has both questions and concerns. Promoting Wellness Beyond Hormone Therapy is written specifically to answer questions for patients whose prostate cancer is considered βhormone-refractory,β meaning that it no longer re
<i><p>Prostate Cancer, Science and Clinical Practice, Second Edition, </i>continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights
Prostate cancer is one of the most common malignancies in men in the Western world. Although a wide range of treatment regimens are available for this disease, there are few evidence-based guidelines for treatment selection. This volume describes the clinical value of imaging for improving not only
This comprehensive and easy-to-read monograph is an authoritative update on clinical prostate cancer. It has been prepared by an international, multidisciplinary team at the invitation of the International Prostate Health Council think tank. A particular strength of the book is its presentation of t